PDGFRB and tarsal-carpal coalition syndrome: As mentioned in Section 3.3.15., it was recently suggested that PDGFR-β could play a role in canine TCC tumourigenesis and that PDGFR-β and VEGFR2 could be involved in mediating clinical response of TCC to toceranib.